Detalles de la búsqueda
1.
Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile.
Ann Hematol
; 102(11): 3015-3023, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37535147
2.
Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study.
Br J Haematol
; 177(5): 741-750, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28419408
3.
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems.
Am J Hematol
; 92(10): 1037-1046, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28675513
4.
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.
Ann Hematol
; 95(7): 1059-65, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27091349
5.
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.
Eur J Haematol
; 96(4): 344-51, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26018238
6.
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes.
Br J Haematol
; 168(3): 361-70, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25272332
7.
An increase in hemoglobin, platelets and white blood cells levels by iron chelation as single treatment in multitransfused patients with myelodysplastic syndromes: clinical evidences and possible biological mechanisms.
Ann Hematol
; 94(5): 771-7, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25743685
8.
Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata.
Eur J Haematol
; 95(1): 52-6, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25764148
9.
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias.
Am J Hematol
; 90(5): E80-5, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25653205
10.
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies.
Ann Hepatol
; 14(2): 168-74, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25671825
11.
Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS).
Br J Haematol
; 185(5): 954-957, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30407614
12.
Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.
Ann Hematol
; 93(8): 1413-20, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24647684
13.
Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial).
Eur J Haematol
; 92(6): 527-36, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24580147
14.
Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical-Biological Entity?
J Clin Med
; 11(9)2022 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35566719
15.
Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study.
Sci Rep
; 10(1): 9156, 2020 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32514107
16.
Real-life experience with azacitidine in myelodysplastic syndromes according to IPSS cytogenetic profile.
Am J Hematol
; 89(5): 565, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24458879
17.
Genomic analysis of therapy-related acute promyelocytic leukemias arising after malignant and non-malignant disorders.
Am J Hematol
; 89(3): 346-7, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24375429
18.
Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
Pediatr Blood Cancer
; 52(3): 357-63, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19061215
19.
A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry.
Mediterr J Hematol Infect Dis
; 9(1): e2017046, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28698789
20.
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide.
Blood Cancer J
; 12(9): 132, 2022 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36071048